|
|
Vaccine Detail
|
Multiantigen Liposome Loaded Dendritic Cell Vaccine |
| Vaccine Information |
- Vaccine Name: Multiantigen Liposome Loaded Dendritic Cell Vaccine
- Target Pathogen: Cancer
- Target Disease: Cancer
- Type: whole cell cancer vaccine
- Status: Clinical trial
- Host Species for Licensed Use: None
- Immunization Route: Intradermal injection (i.d.)
- Description: Advanced Renal Cell Carcinoma patients undergo total nephrectomy to harvest primary tumor for vaccine preparation. Dendritic cells are then pulsed with multiantigens or tumor cells. Some patients also receive vaccination with irradiated autologous tumor lysate. The vaccine may make the body build an immune response to kill tumor cells. (NCT00004880)
|
| Host Response |
|
|
| References |
NCT00004880: Vaccine Therapy in Treating Patients With Advanced Kidney Cancer [https://clinicaltrials.gov/study/NCT00004880]
|
|
